UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): February 10, 2015

 

THORATEC CORPORATION

(Exact name of registrant as specified in its charter)

 

California

(State of Other Jurisdiction of Incorporation)

 

000-49798	94-2340464
(Commission File Number)	(IRS Employer Identification Number)

 

6035 Stoneridge Drive

Pleasanton, California 94588

(Address of principal executive offices including zip code)

 

(925) 847-8600

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

________________

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

Item 2.02 Results of Operations and Financial Condition

 

On February 10, 2015, Thoratec Corporation (the “Company”) issued a press release announcing its fourth quarter ended January 3, 2015 results, the text of which is attached hereto as Exhibit 99.1.

 

The information in this Current Report on Form 8-K, including the exhibit, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities under that Section. Furthermore, the information in the Current Report on Form 8-K, including the exhibit, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended.

 

Item 9.01 Financial Statements and Exhibits

 

(c) Exhibits

 

No.		Exhibit
99.1		Press Release, dated February 10, 2015 regarding results for the fourth quarter ended January 3, 2015.

 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated as of February 10, 2015

 

	THORATEC CORPORATION
	By:	/s/ D. Keith Grossman
		D. Keith Grossman
		President and Chief Executive Officer

 

 

EXHIBIT INDEX

 

No.		Description
99.1		Press Release, dated February 10, 2015 regarding results for the fourth quarter ended January 3, 2015.